Addendum: The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

Affiliations

• ¹ The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, 02142, USA.
• ² Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, 02115, USA.
• ³ Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, 02115, USA.
• ⁴ Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, 02139, USA.
• ⁵ Sage Bionetworks, 1100 Fairview Ave. N., Seattle, Washington, 98109, USA.
• ⁶ Genomics Institute of the Novartis Research Foundation, San Diego, California, 92121, USA.
• ⁷ Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York, 10065, USA.
• ⁸ Novartis Institutes for Biomedical Research, Emeryville, California, 94608, USA.
• ⁹ Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, 02115, USA.
• ¹⁰ Howard Hughes Medical Institute, Chevy Chase, Maryland, 20815, USA.
• ¹¹ Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, 02139, USA. robert.schlegel@novartis.com.
• ¹² The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, 02142, USA. Levi_Garraway@dfci.harvard.edu.
• ¹³ Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, 02115, USA. Levi_Garraway@dfci.harvard.edu.
• ¹⁴ Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, 02115, USA. Levi_Garraway@dfci.harvard.edu.